Abstracts 2025

Abstracts

GRAPPA develops future thought leaders by hosting an annual Trainee Symposium each year during the GRAPPA Annual Meeting. Abstracts from around the world are submitted and the best are chosen to present.

The trainee symposium promotes the dissemination and discussion of research related to dermatology and rheumatology clinical, translational, and basic science proposals.

Seventeen abstract submissions were selected for poster presentations and five were selected for oral presentations at the 2025 GRAPPA Annual Meeting and Trainee Symposium held in Bogota, Colombia on July 10-12.

 

GRAPPA Annual Meeting 2025 (47)
DSCF4170 (1)

Oral Presenters

Maria Gabriella Raimondo University Clinic Erlangen, Germany | Synovial shaping of skin-derived migrating immune cells drives the onset of inflammation in psoriatic arthritis 

Isaac T. Cheng The Chinese University of Hong Kong | Can Achieving Sustained Low Disease Activity Through Treat-to-Target Management Arrest Enthesiophyte Progression in Psoriatic Arthritis? 

Elaine Ma USC Keck School of Medicine, USA | From Plaques to Protection? GLP-1 Receptor Agonists’ Impact on Cardiovascular Events in Psoriasis Patients 

Miranda Chen University of California, San Francisco, USA | Predominantly Genital and Inverse Psoriasis (PGIP): Description of a Unique Psoriasis Subtype 

Dylan McGagh University of Oxford, UK | Association between amount and intensity of accelerometer-measured physical activity and risk of incident psoriatic arthritis in people with psoriasis: a prospective cohort study in the UK Biobank

 

Poster Presenters

A murine model of psoriasis and atopic dermatitis induced with a combination of systemic IL-23 overexpression and topical application of the vitamin D3 analog MC903

ADALIMUMAB vs. IXEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS: A REAL-WORLD MULTICENTER STUDY WITH MATCH-ADJUSTED COMPARISONS

An ex vivo co-culture model of murine skin and lymph nodes to represent psoriatic inflammation and identify novel treatments

Body composition changes in patients with psoriatic disease: a cross-sectional analysis of the UK Biobank cohort

CLA+ effector memory T Cells in circulation associate with DMARD non-response in psoriatic arthritis

Cross-Sectional Analysis of Subclinical Arthritis Based on Family History -Based Risk Score (FRS)

Difficult-to-Treat Psoriatic Arthritis (D2T) in the RECCAPSO Cohort: Prevalence, Characteristics, and Treatment Approaches

Exploring the Synergistic Effects of IL-17A and IL-17F on Neutrophil Chemotaxis: Risk of Candidiasis with Dual Blockade of IL-17A and IL17-F

Impact of environmental exposures, social vulnerability, and pollution on psoriasis

Musculoskeletal Ultrasound as a Predictor of Response to bDMARDs and tsDMARDs in Psoriatic Arthritis

Persistence of Adalimumab treatment in patients with psoriasis, at an immunologically mediated center in Colombia: real-life data

Psoriasis patients’ preferences for interventions to prevent psoriatic arthritis

Real-World Characteristics and Treatment Patterns of Difficult-to-Treat Psoriatric Arthritis

Serum proteomic analysis of cellular immune clusters in psoriatic arthritis

Therapeutic Approach in Patients with Arthralgia at Risk of Progression to Psoriatic Arthritis.

Treat-to-Target Approaches in Early Psoriatic Arthritis: 1 Year Results of STAMP Study

Two-year real-world drug survival of bimekizumab for adult patients with plaque psoriasis: A multicenter retrospective study